The aim of this study was to evaluate the clinical significance of N-myc downstream-regulated gene 1 (NDRG1) in
colorectal cancer (CRC) patients and to explore the mechanisms governing the role of NDRG1 in apoptosis of CRC cells. In the current study, we found that NDRG1 was a prognostic marker of CRC patients. Moreover, NDRG1 expression negatively correlated to
tumor size and clinical TNM stage, suggesting that NDRG1 might act as a
tumor suppressor by inhibiting proliferation or inducing apoptosis in CRC. Consistently, substantial apoptosis was observed in vitro and in vivo in the presence of NDRG1. From a mechanistic standpoint, we discovered that NDRG1 was able to prevent
death receptor 4 from degradation induced by MARCH-8, a member of the membrane-associated RING-CH (MARCH)
ubiquitin ligase family. As a consequence, CRC cells expressing NDRG1 were more sensitive to
reagents targeting
death receptors such as
tumor necrosis factor-related apoptosis-inducing
ligands (TRAIL). Additionally, the pro-apoptotic effect of NDRG1 was also validated in mouse xenograft model. In conclusion, our results provided further insights of the pivotal role of NDRG1 in apoptosis initiated by
death receptors and demonstrated a novel marker to predict the sensitivity of CRC to TRAIL treatment in future clinical study.